Lipopolysaccharide (LPS) inhalation causes an increase in mucosal CD8+ve cells

M. I. Allenby, M. W. Lethbridge, A. R. Sousa, R. I. Ketchell, F. W. Woisin, M. Jensen, D. M. Kemeny, B. J. O'Connor (London, United Kingdom)

Source: Annual Congress 2001 - Inflammatory mechanisms of COPD
Session: Inflammatory mechanisms of COPD
Session type: Oral Presentation
Number: 2117
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Neutrophils are prominent in the airways of patients with chronic obstructive pulmonary disease (COPD), while there are increased numbers of mucosal CD8+ve cells. LPS inhalation causes influx of neutrophils and lymphocytes into sputum (Michel, Nagy, et al. 1997). Chronic inhalation of LPS causes emphysema in mice, and LPS is present in cigarette smoke. Little is known of the effect of LPS inhalation on mucosal inflammatory cell content. METHODS: Seven normal volunteers underwent bronchial biopsy twice, a week apart, the first six hours after inhaling normal saline, and the second after inhaling 50μg LPS. Immunohistochemistry was used to identify cells expressing CD4, CD8, neutrophil elastase (HNE) and major basic protein (MBP).
RESULTS: see table.
CONCLUSIONS: Inhalation of LPS causes an increase in the number of CD8+ve cells, but not neutrophils, within the airway mucosa. This challenge model may be a useful surrogate tool to assess early airway inflammation in COPD.

Neutrophils (HNE+ve)Eosinophils (MBP+ve)CD4+veCD8+veCD4:CD8 ratio
Post saline141 (90 – 235)14 (-13 – 68)517 (238 – 1153)333 (235 – 459)1.50 (0.69 – 3.69)
Post LPS160 (104 – 285)27 (-7 – 106)356 (183 – 723)516 (378 – 676)0.90 (0.30 – 1.74)
p=nsnsns0.03130.0156




Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. I. Allenby, M. W. Lethbridge, A. R. Sousa, R. I. Ketchell, F. W. Woisin, M. Jensen, D. M. Kemeny, B. J. O'Connor (London, United Kingdom). Lipopolysaccharide (LPS) inhalation causes an increase in mucosal CD8+ve cells. Eur Respir J 2001; 16: Suppl. 31, 2117

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lipopolysaccharide (LPS) inhalation causes an increase in activated neutrophils and lymphocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001

Differential properties of mucosubstance produced by allergic inflammation and lipopolysaccharide (LPS) stimulation in rat nasal epithelium
Source: Eur Respir J 2002; 20: Suppl. 38, 482s
Year: 2002

Effects of HSP70 induction on IL-6 production from murine alveolar epithelial cells pre-treated with endotoxine after subsequent endotoxin challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 346s
Year: 2005

Effect of lipopolysaccharide (LPS) priming on Candida-induced acute lung injury (ALI)
Source: Eur Respir J 2003; 22: Suppl. 45, 585s
Year: 2003

Myeloperoxidase -/- mice show decreased lung neutrophilia and increased epithelial cell proliferation after lipopolysaccharide or asbestos exposure
Source: Eur Respir J 2006; 28: Suppl. 50, 398s
Year: 2006

Lidocaine effect on airway neutrophilia caused by LPS mice in vivo
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003

LPS induced airway inflammation in man
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009

Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin
Source: Eur Respir J 2006; 28: 622-626
Year: 2006



Inflammatory response and epithelial-mesenchymal transition based on the model of co-cultured alveolar epithelial cells and monocytes induced by lipopolysaccharide.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

The failure rate of sputum induction following inhaled lipopolysaccharide (LPS) challenge in healthy subjects
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008


TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Adrenaline stimulated mesenchymal stem cells modulate inflammation in lipopolysaccharide induced lung injury
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012


Extracellular vesicles derived from mesenchymal stem cells prevent pulmonary vascular dysfunction induced by lipopolysaccharide (LPS).
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009

The crosstalk between neutrophils and lung epithelial cells upon endotoxin exposure
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010

Cigarette smoke increases TLR4 expression and modifies LPS mediated responses in airway epithelial cells
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Increased expression of microRNA-146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010

Repeated exposure to hydrogen peroxide enhances TGF-ß and LPS dependent inflammatory responses in BEAS-2B cells
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Intratracheal instillation of antigen-pulsed macrophages mediates repression of allergic airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003

Overproduction of IL-18 in the lungs induces IL-13 and IFN-g producing CD4+ T cell in the lungs, and results in airway hyperresponsiveness in Balb/c mice
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011